Cargando...
Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma
The treatment paradigm for advanced and metastatic renal cell carcinoma (mRCC) has evolved rapidly since the arrival of targeted therapies and novel immunotherapies. mRCC was previously treated only with cytokines. However, discoveries of mutations affecting the von Hippel-Lindau tumor suppressor ge...
Gardado en:
| Publicado en: | Am Soc Clin Oncol Educ Book |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855178/ https://ncbi.nlm.nih.gov/pubmed/28561652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_174469 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|